220 related articles for article (PubMed ID: 31702544)
1. Controversial issues in the management of patients with advanced prostate cancer: Results from a Canadian consensus forum.
Saad F; Canil C; Finelli A; Hotte SJ; Malone S; Shayegan B; So AI; Aaron L; Basappa NS; Conter HJ; Danielson B; Gotto G; Hamilton RJ; Izard JP; Kapoor A; Kolinsky M; Lalani AA; Lattouf JB; Morash C; Morgan SC; Niazi T; Noonan KL; Ong M; Rendon RA; Sehdev S; Hew H; Park-Wyllie L; Chi KN
Can Urol Assoc J; 2020 Apr; 14(4):E137-E149. PubMed ID: 31702544
[TBL] [Abstract][Full Text] [Related]
2. Results from a Canadian consensus forum of key controversial areas in the management of advanced prostate cancer: Recommendations for Canadian healthcare providers.
Saad F; Hotte SJ; Finelli A; Malone S; Niazi T; Noonan K; Shayegan B; So AI; Danielson B; Basappa NS; Cagiannos I; Canil C; Delouya G; Fernandes R; Ferrario C; Gotto GT; Hamilton RJ; Izard JP; Kapoor A; Khalaf D; Kolinsky M; Lalani AK; Lavallée LT; Morash C; Morgan SC; Ong M; Pouliot F; Rendon RA; Yip S; Zardan A; Park-Wyllie L; Chi K
Can Urol Assoc J; 2021 Oct; 15(10):353-358. PubMed ID: 34125066
[TBL] [Abstract][Full Text] [Related]
3. Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022.
Gillessen S; Bossi A; Davis ID; de Bono J; Fizazi K; James ND; Mottet N; Shore N; Small E; Smith M; Sweeney CJ; Tombal B; Antonarakis ES; Aparicio AM; Armstrong AJ; Attard G; Beer TM; Beltran H; Bjartell A; Blanchard P; Briganti A; Bristow RG; Bulbul M; Caffo O; Castellano D; Castro E; Cheng HH; Chi KN; Chowdhury S; Clarke CS; Clarke N; Daugaard G; De Santis M; Duran I; Eeles R; Efstathiou E; Efstathiou J; Ekeke ON; Evans CP; Fanti S; Feng FY; Fonteyne V; Fossati N; Frydenberg M; George D; Gleave M; Gravis G; Halabi S; Heinrich D; Herrmann K; Higano C; Hofman MS; Horvath LG; Hussain M; Jereczek-Fossa BA; Jones R; Kanesvaran R; Kellokumpu-Lehtinen PL; Khauli RB; Klotz L; Kramer G; Leibowitz R; Logothetis C; Mahal B; Maluf F; Mateo J; Matheson D; Mehra N; Merseburger A; Morgans AK; Morris MJ; Mrabti H; Mukherji D; Murphy DG; Murthy V; Nguyen PL; Oh WK; Ost P; O'Sullivan JM; Padhani AR; Pezaro CJ; Poon DMC; Pritchard CC; Rabah DM; Rathkopf D; Reiter RE; Rubin MA; Ryan CJ; Saad F; Sade JP; Sartor O; Scher HI; Sharifi N; Skoneczna I; Soule H; Spratt DE; Srinivas S; Sternberg CN; Steuber T; Suzuki H; Sydes MR; Taplin ME; Tilki D; Türkeri L; Turco F; Uemura H; Uemura H; Ürün Y; Vale CL; van Oort I; Vapiwala N; Walz J; Yamoah K; Ye D; Yu EY; Zapatero A; Zilli T; Omlin A
Eur J Cancer; 2023 May; 185():178-215. PubMed ID: 37003085
[TBL] [Abstract][Full Text] [Related]
4. Addressing controversial areas in the management of advanced prostate cancer in Canada Areas of consensus and controversy from the third Canadian consensus forum.
Saad F; Hotte SJ; Noonan K; Malone S; Morash C; Niazi T; Rendon RA; Shayegan B; Basappa NS; Cagiannos I; Danielson B; Delouya G; Fernandes R; Ferrario C; Finelli A; Gotto GT; Hamilton RJ; Izard JP; Kapoor A; Lalani AK; Lavallée LT; Ong M; Pouliot F; So AI; Yip S; Chi KN
Can Urol Assoc J; 2024 Apr; 18(4):E127-E137. PubMed ID: 38381937
[TBL] [Abstract][Full Text] [Related]
5. Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022.
Gillessen S; Bossi A; Davis ID; de Bono J; Fizazi K; James ND; Mottet N; Shore N; Small E; Smith M; Sweeney C; Tombal B; Antonarakis ES; Aparicio AM; Armstrong AJ; Attard G; Beer TM; Beltran H; Bjartell A; Blanchard P; Briganti A; Bristow RG; Bulbul M; Caffo O; Castellano D; Castro E; Cheng HH; Chi KN; Chowdhury S; Clarke CS; Clarke N; Daugaard G; De Santis M; Duran I; Eeles R; Efstathiou E; Efstathiou J; Ngozi Ekeke O; Evans CP; Fanti S; Feng FY; Fonteyne V; Fossati N; Frydenberg M; George D; Gleave M; Gravis G; Halabi S; Heinrich D; Herrmann K; Higano C; Hofman MS; Horvath LG; Hussain M; Jereczek-Fossa BA; Jones R; Kanesvaran R; Kellokumpu-Lehtinen PL; Khauli RB; Klotz L; Kramer G; Leibowitz R; Logothetis CJ; Mahal BA; Maluf F; Mateo J; Matheson D; Mehra N; Merseburger A; Morgans AK; Morris MJ; Mrabti H; Mukherji D; Murphy DG; Murthy V; Nguyen PL; Oh WK; Ost P; O'Sullivan JM; Padhani AR; Pezaro C; Poon DMC; Pritchard CC; Rabah DM; Rathkopf D; Reiter RE; Rubin MA; Ryan CJ; Saad F; Pablo Sade J; Sartor OA; Scher HI; Sharifi N; Skoneczna I; Soule H; Spratt DE; Srinivas S; Sternberg CN; Steuber T; Suzuki H; Sydes MR; Taplin ME; Tilki D; Türkeri L; Turco F; Uemura H; Uemura H; Ürün Y; Vale CL; van Oort I; Vapiwala N; Walz J; Yamoah K; Ye D; Yu EY; Zapatero A; Zilli T; Omlin A
Eur Urol; 2023 Mar; 83(3):267-293. PubMed ID: 36494221
[TBL] [Abstract][Full Text] [Related]
6. Real-world management of advanced prostate cancer: A description of management practices of community-based physicians and prostate cancer specialists.
Hotte SJ; Finelli A; Chi KN; Canil C; Fleshner N; Kapoor A; Kolinsky M; Malone S; Morash C; Niazi T; Noonan KL; Ong M; Pouliot F; Shayegan B; So AI; Sorabji D; Hew H; Park-Wyllie L; Saad F
Can Urol Assoc J; 2021 Feb; 15(2):E90-E96. PubMed ID: 32853135
[TBL] [Abstract][Full Text] [Related]
7. Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019.
Gillessen S; Attard G; Beer TM; Beltran H; Bjartell A; Bossi A; Briganti A; Bristow RG; Chi KN; Clarke N; Davis ID; de Bono J; Drake CG; Duran I; Eeles R; Efstathiou E; Evans CP; Fanti S; Feng FY; Fizazi K; Frydenberg M; Gleave M; Halabi S; Heidenreich A; Heinrich D; Higano CTS; Hofman MS; Hussain M; James N; Kanesvaran R; Kantoff P; Khauli RB; Leibowitz R; Logothetis C; Maluf F; Millman R; Morgans AK; Morris MJ; Mottet N; Mrabti H; Murphy DG; Murthy V; Oh WK; Ost P; O'Sullivan JM; Padhani AR; Parker C; Poon DMC; Pritchard CC; Reiter RE; Roach M; Rubin M; Ryan CJ; Saad F; Sade JP; Sartor O; Scher HI; Shore N; Small E; Smith M; Soule H; Sternberg CN; Steuber T; Suzuki H; Sweeney C; Sydes MR; Taplin ME; Tombal B; Türkeri L; van Oort I; Zapatero A; Omlin A
Eur Urol; 2020 Apr; 77(4):508-547. PubMed ID: 32001144
[TBL] [Abstract][Full Text] [Related]
8. Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017.
Gillessen S; Attard G; Beer TM; Beltran H; Bossi A; Bristow R; Carver B; Castellano D; Chung BH; Clarke N; Daugaard G; Davis ID; de Bono J; Borges Dos Reis R; Drake CG; Eeles R; Efstathiou E; Evans CP; Fanti S; Feng F; Fizazi K; Frydenberg M; Gleave M; Halabi S; Heidenreich A; Higano CS; James N; Kantoff P; Kellokumpu-Lehtinen PL; Khauli RB; Kramer G; Logothetis C; Maluf F; Morgans AK; Morris MJ; Mottet N; Murthy V; Oh W; Ost P; Padhani AR; Parker C; Pritchard CC; Roach M; Rubin MA; Ryan C; Saad F; Sartor O; Scher H; Sella A; Shore N; Smith M; Soule H; Sternberg CN; Suzuki H; Sweeney C; Sydes MR; Tannock I; Tombal B; Valdagni R; Wiegel T; Omlin A
Eur Urol; 2018 Feb; 73(2):178-211. PubMed ID: 28655541
[TBL] [Abstract][Full Text] [Related]
9. Bone health and body composition in prostate cancer: Meet-URO and AIOM consensus about prevention and management strategies.
Cursano MC; Valsecchi AA; Pantano F; Di Maio M; Procopio G; Berruti A; Bertoldo F; Tucci M; De Giorgi U; Santini D;
ESMO Open; 2024 Jun; 9(7):103484. PubMed ID: 38901175
[TBL] [Abstract][Full Text] [Related]
10. Management of Patients with Advanced Prostate Cancer: Report from the Advanced Prostate Cancer Consensus Conference 2021.
Gillessen S; Armstrong A; Attard G; Beer TM; Beltran H; Bjartell A; Bossi A; Briganti A; Bristow RG; Bulbul M; Caffo O; Chi KN; Clarke CS; Clarke N; Davis ID; de Bono JS; Duran I; Eeles R; Efstathiou E; Efstathiou J; Ekeke ON; Evans CP; Fanti S; Feng FY; Fizazi K; Frydenberg M; George D; Gleave M; Halabi S; Heinrich D; Higano C; Hofman MS; Hussain M; James N; Jones R; Kanesvaran R; Khauli RB; Klotz L; Leibowitz R; Logothetis C; Maluf F; Millman R; Morgans AK; Morris MJ; Mottet N; Mrabti H; Murphy DG; Murthy V; Oh WK; Ost P; O'Sullivan JM; Padhani AR; Parker C; Poon DMC; Pritchard CC; Rabah DM; Rathkopf D; Reiter RE; Rubin M; Ryan CJ; Saad F; Sade JP; Sartor O; Scher HI; Shore N; Skoneczna I; Small E; Smith M; Soule H; Spratt DE; Sternberg CN; Suzuki H; Sweeney C; Sydes MR; Taplin ME; Tilki D; Tombal B; Türkeri L; Uemura H; Uemura H; van Oort I; Yamoah K; Ye D; Zapatero A; Omlin A
Eur Urol; 2022 Jul; 82(1):115-141. PubMed ID: 35450732
[TBL] [Abstract][Full Text] [Related]
11. Management of advanced prostate cancer in a middle-income country: real-world consideration of the Advanced Prostate Cancer Consensus Conference 2017.
Saad M; Alip A; Lim J; Abdullah MM; Chong FLT; Chua CB; Ismail F; Khong RK; Lim CS; Loh CS; Malek R; Mohd Ghani KA; Md Noor I; Md Yusoff NA; Nasuha NA; Razack A; Soo Hoo HF; Sundram M; Tan HM; Thiagarajan M; Teh GC; Voon PJ; Ong TA
BJU Int; 2019 Sep; 124(3):373-382. PubMed ID: 31077523
[TBL] [Abstract][Full Text] [Related]
12. Oligometastatic Prostate Cancer: Results of a Dutch Multidisciplinary Consensus Meeting.
Aluwini SS; Mehra N; Lolkema MP; Oprea-Lager DE; Yakar D; Stoevelaar H; van der Poel H; ; Busstra M; de Jong IJ; de Reijke T; de Vries K; Heijmink S; Jenster G; Klaver S; Kneppers J; Lavalaye J; Leyten G; Moonen L; Nagaraj J; Noordzij W; Osanto S; Oving I; Schaake E; Scheenen T; Schoots I; Sedelaar M; Somford D; van den Berkmortel F; van der Hulle T; van der Voort van Zyp J; van Leeuwen P; van Moorselaar J; van Oort I; Vogel W; Westgeest H
Eur Urol Oncol; 2020 Apr; 3(2):231-238. PubMed ID: 31401014
[TBL] [Abstract][Full Text] [Related]
13. Optimizing the management of castration-resistant prostate cancer patients: A practical guide for clinicians.
Shore ND; Drake CG; Lin DW; Ryan CJ; Stratton KL; Dunshee C; Karsh LI; Kaul S; Kernen K; Pieczonka C; Sieber P; Stewart C; Williams M; Concepcion RS
Prostate; 2020 Oct; 80(14):1159-1176. PubMed ID: 32779781
[TBL] [Abstract][Full Text] [Related]
14. Genetic Aspects and Molecular Testing in Prostate Cancer: A Report from a Dutch Multidisciplinary Consensus Meeting.
Mehra N; Kloots I; Vlaming M; Aluwini S; Dewulf E; Oprea-Lager DE; van der Poel H; Stoevelaar H; Yakar D; Bangma CH; Bekers E; van den Bergh R; Bergman AM; van den Berkmortel F; Boudewijns S; Dinjens WNM; Fütterer J; van der Hulle T; Jenster G; Kroeze LI; van Kruchten M; van Leenders G; van Leeuwen PJ; de Leng WWJ; van Moorselaar RJA; Noordzij W; Oldenburg RA; van Oort IM; Oving I; Schalken JA; Schoots IG; Schuuring E; Smeenk RJ; Vanneste BGL; Vegt E; Vis AN; de Vries K; Willemse PM; Wondergem M; Ausems M
Eur Urol Open Sci; 2023 Mar; 49():23-31. PubMed ID: 36874601
[TBL] [Abstract][Full Text] [Related]
15. Sequencing of Systemic Therapies in the Management of Advanced Prostate Cancer in India: a Delphi-Based Consensus.
Desai C; Vaid AK; Biswas G; Batra S; Dattatreya PS; Mohapatra PN; Dabkara D; Gore A; Bhagat SB; Patil S; Barkate H
Oncol Ther; 2022 Jun; 10(1):143-165. PubMed ID: 35025089
[TBL] [Abstract][Full Text] [Related]
16. Optimal management of metastatic castration-resistant prostate cancer: highlights from a European Expert Consensus Panel.
Fitzpatrick JM; Bellmunt J; Fizazi K; Heidenreich A; Sternberg CN; Tombal B; Alcaraz A; Bahl A; Bracarda S; Di Lorenzo G; Efstathiou E; Finn SP; Fosså S; Gillessen S; Kellokumpu-Lehtinen PL; Lecouvet FE; Oudard S; de Reijke TM; Robson CN; De Santis M; Seruga B; de Wit R
Eur J Cancer; 2014 Jun; 50(9):1617-27. PubMed ID: 24703899
[TBL] [Abstract][Full Text] [Related]
17. Management of high-risk and post-operative non-metastatic prostate cancer in Catalonia: an expert Delphi consensus.
Bonet M; González D; Baquedano JE; García E; Altabas M; Casas F; Feltes N; Ferrer F; Foro P; Fuentes R; Galdeano M; Gomez D; Henriquez I; Jové J; Lozano J; Maldonado X; Mases J; Membrive I; Paredes S; Roselló À; Sancho G; Mira M
Clin Transl Oncol; 2023 Apr; 25(4):1017-1023. PubMed ID: 36436177
[TBL] [Abstract][Full Text] [Related]
18. Management of advanced prostate cancer in Hong Kong: Insights from an APCCC-Derived survey.
Poon DM; Ma WK; Chan TW; Ho FK; Ho LY; Leung AK; Leung SY; Sze HC; Kwong PW; Chan ES
Asia Pac J Clin Oncol; 2019 Oct; 15 Suppl 6():8-13. PubMed ID: 31642191
[TBL] [Abstract][Full Text] [Related]
19. Management of patients with advanced prostate cancer in Japan: 'real-world' consideration of the results from the Advanced Prostate Cancer Consensus Conference.
Fujita K; Suzuki H; Hinata N; Miura Y; Edamura K; Tabata KI; Arai G; Matsubara N; Yasumizu Y; Kosaka T; Oya M; Sugimoto M
Transl Androl Urol; 2022 Dec; 11(12):1771-1785. PubMed ID: 36632151
[TBL] [Abstract][Full Text] [Related]
20. Consensus on management of castration-resistant prostate cancer on behalf of the Urological Tumours Working Group (URONCOR) of the Spanish Society of Radiation Oncology.
Gómez-Caamaño A; González-San Segundo C; Henríquez I; Maldonado X; Zapatero A;
Clin Transl Oncol; 2019 Apr; 21(4):420-432. PubMed ID: 30293231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
